NCT03252457 Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP Status UNKNOWN Phase PHASE3
NCT03229746 Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia Status COMPLETED Phase PHASE4
NCT03201848 The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03183284 Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra Status UNKNOWN Phase N/A
NCT03172676 Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura Status UNKNOWN Phase PHASE4
NCT03164915 A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE3
NCT03156452 Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate Status COMPLETED Phase PHASE3
NCT03154385 Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia Status COMPLETED Phase NA
NCT03033199 Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT03013114 A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) Status UNKNOWN Phase PHASE2
NCT02877706 French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia Status RECRUITING Phase N/A
NCT02868099 Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE3
NCT02859909 This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE3
NCT02834468 DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients Status UNKNOWN Phase PHASE3
NCT02834286 Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia Status UNKNOWN Phase PHASE2